Abnormal condition that negatively affects an organism
POPULARITY
Categories
Chronic Wasting Disease (CWD) is more than just a wildlife issue—it's a crisis reshaping Missouri's deer hunting culture and threatening our landowners' way of life. With confusion, controversy, and misinformation running rampant, Brandon Butler and Nathan “Shags” McLeod of Driftwood Outdoors are hosting a powerful, event to cut through the noise and get to the truth.Recorded live at Runge Nature Center, this episode brings together some of the most respected voices in wildlife conservation:Kip Adams of the National Deer Association explains the science behind CWD.Doug Duren, land steward and Wisconsin conservationist, shares a cautionary tale from a state that stopped fighting back.Jason Sumners, Director of the Missouri Department of Conservation, outlines the state's strategy to manage and contain the disease.Moderated by Brandon Butler, the evening wraps with an unfiltered panel discussion featuring questions from real hunters and landowners. If you care about Missouri deer hunting, this is a conversation you can't afford to miss. For more info:Missouri Dept of ConservationNational Deer AssociationSpecial thanks to:Living The Dream Outdoor PropertiesSuperior Foam Insulation LLCDoolittle TrailersScenic Rivers TaxidermyConnect with Driftwood Outdoors:FacebookInstagramYouTubeEmail:info@driftwoodoutdoors.com
Laura Fox is the founder of i am Laura, who helps women and mothers with chronic illness build and run their own businesses through personalized coaching and accountability support.Through her signature Clarity & Confidence Success Accelerator package, Laura guides clients to develop sustainable businesses that accommodate their health challenges, drawing from her own experiences with Crohn's Disease and bilateral facial pain.Now, Laura's journey from high school math teacher to business owner demonstrates how choosing bravery can transform even the most challenging health circumstances into opportunities for growth.And while balancing her life in Cornwall with her two daughters and ongoing health management, she's showing others with chronic illness that they don't have to keep their lives small due to their conditions.Here's where to find more:https://iamlaura.co.ukhttps://www.facebook.com/iamlaurapodcasthttps://www.instagram.com/iamlaura_chronicmumsbizcoachMy free Facebook group, a supportive community: https://www.facebook.com/groups/919801906650104My podcastsJuggling Chronic Illness, Kids, a Job and a Dream: https://i-am-laura-podcast.captivate.fmA Sprinkle of Sunshine: https://a-sprinkle-of-sunshine.captivate.fm________________________________________________Welcome to The Unforget Yourself Show where we use the power of woo and the proof of science to help you identify your blind spots, and get over your own bullshit so that you can do the fucking thing you ACTUALLY want to do!We're Mark and Katie, the founders of Unforget Yourself and the creators of the Unforget Yourself System and on this podcast, we're here to share REAL conversations about what goes on inside the heart and minds of those brave and crazy enough to start their own business. From the accidental entrepreneur to the laser-focused CEO, we find out how they got to where they are today, not by hearing the go-to story of their success, but talking about how we all have our own BS to deal with and it's through facing ourselves that we find a way to do the fucking thing.Along the way, we hope to show you that YOU are the most important asset in your business (and your life - duh!). Being a business owner is tough! With vulnerability and humor, we get to the real story behind their success and show you that you're not alone._____________________Find all our links to all the things like the socials, how to work with us and how to apply to be on the podcast here: https://linktr.ee/unforgetyourself
Parkinson's disease affects nearly a million Americans — and as our population ages, that number is growing. But there's hope. New research and cutting‑edge treatments, from deep brain stimulation to breakthrough medications, are changing lives.
Welcome back to our weekend Cabral HouseCall shows! This is where we answer our community's wellness, weight loss, and anti-aging questions to help people get back on track! Check out today's questions: Trish: Hi Dr. Cabral - I'm a 55-year-old female working on lowering overall inflammation in my body. My CRP levels are (4.1), ApoB (118 nmol/L and Lipoprotein (A) (281 nmol/L) as you can see are high. Total Cholesterol 221 and Triglycerides are 70. I have a lot of stiffness with joint discomfort. I started taking 2 Proteolytic Enzymes upon waking. Then your DNS, D3/k2, Cell Boost, Inflamma Soothe, Collagen with GLP Tone System and some of your other products (eye and hair). I follow your Med diet. My pain and stiffness have improved ALOT in a matter of days. I'm going to retest my CRP and chol levels in 4 months. My question is how long can I take Proteolytic Enzymes and in your opinion am I taking the proper protocol for these issues? I'm retesting in 4 mos. Thank you in advance Sheena: Hi Dr Cabral! Hope you and all of your health family are well. I'm a surgical Processor and on my feet all day. I've tried all kinds of compression socks but by the end of the day, after taking it off, my leg are soo itchy! I scratch it sometimes so bad it starts to bleed. I'm only wearing the average 15-20 mmHG so its not too tight. I'm curious if you have a recommendation for compression socks that wont causes itching but is effective? Thanks in advance for answering! Christina: Stephen, I have listened on one of your podcasts about Rheumatoid Arthritis and detoxing. My mother is in her early 70s and her fingers are twisting. I am 48 and recently the base of my thumbs have started bothering me. My question is, what detox protocol should my mother start with to prevent further twisting of her fingers and what detox protocol should I do to prevent this from happening to me? I would love to do the heavy metals and organic acid tests, but unfortunately I live in NY. Would my functional medicine doctor be able to order them for me? I have had HELLP, HUS, DIC, Guillian Barre, and Pulminary Edema in my pregnancy at 21. My son was delivered with no issues! At this time, we learned that I have ITTP. I have had IBS issues. Thank you, Christina Ryan: Hi dr cabral, Im a 29 year old male who has addisons disease, chronic post nasal drip, food intolerance's and teeth grinding a stool test confirmed klebsiella pneumonie overgrowth and blastocystis hominis as well as some yeast and fungus with no Bifidobacteria and Lactobacillus detected, I recently started the cbo protocol with citricidal drops im 7 days in untill i came across one of your videos where you mentioned you should go for the parasite first should i stop the cbo protocol and start the para support protocol and then continue the cbo after or just continue the cbo protocol Thank you for your time wishing you all the best ryan. Kay: Hi Dr. Cabral, I I love your podcasts and look forward to them every week. Anyway, I was wondering if you could please explain how a traumatic event could spur the onset of a "dis-ease" such as asthma. My daughter's asthma began shortly after her father and I were separated and he moved out of state. According to her pediatrician at the time, she was "more prone to having asthma because she also had eczema." This was 2 decades ago, and now she's 31 and we know more about autoimmune issues. Although she continues to carry an inhaler with her, she hardly needs to use it anymore. What would you recommend for a more root cause approach to someone with her condition? Thank you. Thank you for tuning into today's Cabral HouseCall and be sure to check back tomorrow where we answer more of our community's questions! - - - Show Notes and Resources: StephenCabral.com/3466 - - - Get a FREE Copy of Dr. Cabral's Book: The Rain Barrel Effect - - - Join the Community & Get Your Questions Answered: CabralSupportGroup.com - - - Dr. Cabral's Most Popular At-Home Lab Tests: > Complete Minerals & Metals Test (Test for mineral imbalances & heavy metal toxicity) - - - > Complete Candida, Metabolic & Vitamins Test (Test for 75 biomarkers including yeast & bacterial gut overgrowth, as well as vitamin levels) - - - > Complete Stress, Mood & Metabolism Test (Discover your complete thyroid, adrenal, hormone, vitamin D & insulin levels) - - - > Complete Food Sensitivity Test (Find out your hidden food sensitivities) - - - > Complete Omega-3 & Inflammation Test (Discover your levels of inflammation related to your omega-6 to omega-3 levels) - - - Get Your Question Answered On An Upcoming HouseCall: StephenCabral.com/askcabral - - - Would You Take 30 Seconds To Rate & Review The Cabral Concept? The best way to help me spread our mission of true natural health is to pass on the good word, and I read and appreciate every review!
Barry who is now 39 years olds is 6 years into his diagnosis with Addison's Disease. He continues living his high stress, highly active career as a college level tennis coach. He offers invaluable insights of managing his illness and thriving at life. Information and inspiration those seeking a diagnosis, the newly dx or those who have been livign with Addison's for years. Barry has always been proactive in his health and wellbeing which helped him with an early diagnosis at the dermatologist's office. Tune in and find how Barry's diagnosis evolved from a. routine visit with the dermatologist to a life saving and changing diagnosisi.Have an episode you found meaning and helpful. Please commented share. Help others find the information and guest stories that can change their lives.POPULAR VIDEOS
In this episode, we review the high-yield topic Paget Disease of the Breast from the Oncology section at Medbullets.comFollow Medbullets on social media:Facebook: www.facebook.com/medbulletsInstagram: www.instagram.com/medbulletsofficialTwitter: www.twitter.com/medbulletsLinkedin: https://www.linkedin.com/company/medbullets
Steven Thompson is the co-founder of Analemma Wines in Mosier, Oregon, where he and his team have transformed a conventional cherry orchard into a vibrant, biodynamic vineyard. With a background in wine and viticulture, Steven focuses on creating a farm that reflects beauty, biodiversity, and intentional design. Through regenerative practices, Steven has eliminated synthetic inputs, transitioned to dry farming, and built soil health using sap analysis, foliar nutrition, and microbial inoculants. His approach has improved vine vigor, reduced pest pressure, and enabled clean native yeast fermentations that capture a true sense of place. In this episode, John and Steven discuss: Transitioning from conventional cherries to biodynamic grapes Attracting pollinators with lavender and flowering hedgerows Managing powdery mildew with balanced nutrition and biologicals Soil improvements that enabled dry farming and deeper roots Using sap analysis to reduce foliar input dependency Boosting disease resistance through regenerative practices Additional Resources To learn more about Steven and Analemma Wines, please visit: https://analemmawines.com/ To download a copy of the Plant Health Pyramid, developed by John Kempf, please visit: https://advancingecoag.com/plant-health-pyramid/ About John Kempf John Kempf is the founder of Advancing Eco Agriculture (AEA). A top expert in biological and regenerative farming, John founded AEA in 2006 to help fellow farmers by providing the education, tools, and strategies that will have a global effect on the food supply and those who grow it. Through intense study and the knowledge gleaned from many industry leaders, John is building a comprehensive systems-based approach to plant nutrition – a system solidly based on the sciences of plant physiology, mineral nutrition, and soil microbiology. Support For This Show & Helping You Grow Since 2006, AEA has been on a mission to help growers become more resilient, efficient, and profitable with regenerative agriculture. AEA works directly with growers to apply its unique line of liquid mineral crop nutrition products and biological inoculants. Informed by cutting-edge plant and soil data-gathering techniques, AEA's science-based programs empower farm operations to meet the crop quality markers that matter the most. AEA has created real and lasting change on millions of acres with its products and data-driven services by working hand-in-hand with growers to produce healthier soil, stronger crops, and higher profits. Beyond working on the ground with growers, AEA leads in regenerative agriculture media and education, producing and distributing the popular and highly-regarded Regenerative Agriculture Podcast, inspiring webinars, and other educational content that serve as go-to resources for growers worldwide. Learn more about AEA's regenerative programs and products: https://www.advancingecoag.com
Sometimes, after a bad night of sleep, I look in the mirror and say, "Oh girl, you look so tired." Before I know it, I start to "act" tired. This means I slump my shoulders, shuffle my feet when I walk, and let the fatigue take over. Worst of all, I start believing the story that says, "Oh girl, you're so tired. How will you get through the day?" Today's guest, Dane Johnson, founder of The Crohns/Colitis Lifestyle, struggled with his thoughts during his life-threatening experience with IBD. He said he would look in the mirror and start to act sick. He wouldn't brush his hair, he stopped wearing nicer clothes, and he began to embrace his diagnosis. Dane shared that when he would "act sick", it led him to discover the powerful connection between the mind and body. Surprisingly, acting sick made him feel genuinely worse. I can relate, as I also notice that when I tell myself I'm tired, it often amplifies my exhaustion. It's fascinating how our thoughts influence our well-being! Dane has MANY helpful tips if you're struggling with your mindset. He also shared his SECRET GUT HACKS that have helped him heal from IBD. Here are some of Dane's suggestions, including a link to his morning shake and a link if you'd like to work with him. Natren Probiotics: https://shop.crohnscolitislifestyle.com/collections/top-sellers/products/bifido-factor-digesta-lac-megadophilus-dairy-free-combo-pack Elemental Shake: 1-3 Bananas Frozen Blueberries Frozen mango/Papaya/Melon Marshmallow - https://shop.crohnscolitislifestyle.com/products/organic-marshmallow-root-powder?_pos=1&_sid=85de0d1df&_ss=r Slippery Elm - https://shop.crohnscolitislifestyle.com/products/slippery-elm-powder?_pos=1&_sid=9c72f7878&_ss=r Optional (PurePaleo) - https://www.designsforhealth.com/u/cclifestyle/products/purepaleo-protein/#PPPUNF Click here if you'd like to find out more about Dane's program: https://cclpresentation.com/ibd-relief-special-podcast?source=deborahenospodcast&el=deborahenospodcast ______ Parafy worm kit You're not alone if you've ever wondered what's lurking in your body! Kim Rogers struggled with parasites and worms for years, and now she's created the Parafy Kit—a powerful cleanse designed to help you take control of your health. Here's the link to purchase the parasite cleanse from Kim Rogers: https://rogershood.com/ref/85/0 Use the code: DENOS10 You get 10% off your purchase!Just click the link to grab yours. I'm getting one too—let's do this together! ______ My Newsletter! Sign up Here ______ Connect with Dane Johnson YouTube:https://www.youtube.com/channel/UCf3Yhapgc2Qb16_MP7f-DuQ Instagram: https://www.instagram.com/danejohnson1 Facebook: https://www.facebook.com/CrohnsColitisLifestyle ______ Connect with Deborah Deborah on Instagram: https://www.instagram.com/whydidigetcancer/ Deborah on Facebook: https://www.facebook.com/DebsHealthCoachKitchen Deborah on Twitter: https://twitter.com/ydidigetcancer Deborah on Pinterest: https://in.pinterest.com/whydidigetcancer/ Join Deb's weekly newsletter: https://whydidigetcancerbydeborahenos.myflodesk.com/newslettersignup Learn more about your ad choices. Visit megaphone.fm/adchoices
Dr. Emma Sandoe joins the Exchange. She's the director of Oregon Health Authority's Medicaid Division.
Following a carnivore diet, Cassandra improved alcoholic fatty liver, prediabetes, inflammation (degenerative disc disorder), anxiety, and depression. Instagram: https://www.instagram.com/cass_caelestis/ TikTok: https://www.tiktok.com/@cass_caelestis Timestamps: 00:00 Trailer 00:38 Introduction 03:56 Gestational diabetes and the carnivore diet 08:57 Inspiring family with lifestyle changes 12:24 Cost and controversy of the carnivore diet 13:52 Success with the carnivore diet success 18:17 Reaching goals and dietary shifts 19:53 Increased activity inspires family fitness 23:55 Carnivore diet cures skin issues Join Revero now to regain your health: https://revero.com/YT Revero.com is an online medical clinic for treating chronic diseases with this root-cause approach of nutrition therapy. You can get access to medical providers, personalized nutrition therapy, biomarker tracking, lab testing, ongoing clinical care, and daily coaching. You will also learn everything you need with educational videos, hundreds of recipes, and articles to make this easy for you. Join the Revero team (medical providers, etc): https://revero.com/jobs #Revero #ReveroHealth #shawnbaker #Carnivorediet #MeatHeals #AnimalBased #ZeroCarb #DietCoach #FatAdapted #Carnivore #sugarfree Disclaimer: The content on this channel is not medical advice. Please consult your healthcare provider.
Dementia is a syndrome associated with a decline of brain function that can affect memory, thought processes and behaviour. In some cases this can impact people's ability to shop, cook and eat a meal. The most common form of dementia is Alzheimer's Disease. In this programme Ruth Alexander meets people living with dementia and their families, to hear about the ways in which a diagnosis can impact mealtimes. Ruth meets Alan and Amy Lambert in Manchester, England. Alan was diagnosed with Alzheimer's Disease in 2024 and his daughter Amy lives with him. They share some of the techniques they've developed at home to support Alan. For Ruby Qureshi in Canada, cooking was a huge part of her life before being diagnosed with Alzheimer's in 2020. Ruth hears how her husband Pasha Qureshi has joined her in the kitchen in a supporting role. Jo Bonser in Nottingham, UK shares her experiences of supporting her mother who lived with vascular dementia and in 2016 stopped eating and drinking. Jo has gone on to set up a company, Dignified Dining that offers training in this area. And Aideen McGuinness is a registered dietitian working in the Memory Assessment and Support Service in Country Wexford Ireland, and co-author of a guide on dementia and nutrition. If you would like to get in touch with the show, please email: thefoodchain@bbc.co.uk Produced by Beatrice Pickup. (Image: Alan and Amy Lambert sat at the kitchen table with a bowl of soup and plate of toast. Credit: BBC)
Guest: Ann Schmiesing is professor of German and Scandinavian studies at the University of Colorado Boulder. She is the author of Disability, Deformity, and Disease in the Grimms' Fairy Tales and most lately, The Brothers Grimm: A Biography. The post The Story Behind the Grimm Brothers' Tales appeared first on KPFA.
In part eight of this ten-part series, Dr. Paul Crane and Dr. Prashanth Ramachandran discuss the study findings and the potential impact on clinical practice. Show reference: https://jamanetwork.com/journals/jamaneurology/fullarticle/2824325
This week on Health Matters, we explore how to protect yourself from diseases carried by ticks and mosquitos. Dr. Jennifer Small-Saunders, an infectious disease expert with NewYork-Presbyterian and Columbia, explains why mosquitos are more attracted to some people than others. She also shares symptoms of diseases like West Nile Virus and Lyme Disease, how we can go about our summer activities without getting bitten, and what to do if you've been bitten.___Dr. Jennifer Small-Saunders is an Infectious Diseases physician-scientist who studies molecular mechanisms of antimalarial drug resistance in Plasmodium falciparum parasites. She is a practicing Infectious Diseases physician who sees patients on both the Internal Medicine and Infectious Diseases teaching services. She completed Internal Medicine residency and Infectious Diseases fellowship at Columbia University Irving Medical Center (CUIMC). Her postdoctoral studies investigated the landscape of mutations in the P. falciparum chloroquine resistance transporter PfCRT and how these mutations contribute to parasite resistance to chloroquine and piperaquine in Asia and Africa. Her group now uses mass spectrometry and gene editing techniques to study the role of tRNA modification reprogramming and translational control in resistance to the first line antimalarial, artemisinin. The goal of her group is to uncover stress-response pathways in malaria parasites that can be targeted by new treatments.___Health Matters is your weekly dose of health and wellness information, from the leading experts. Join host Courtney Allison to get news you can use in your own life. New episodes drop each Wednesday.If you are looking for practical health tips and trustworthy information from world-class doctors and medical experts you will enjoy listening to Health Matters. Health Matters was created to share stories of science, care, and wellness that are happening every day at NewYork-Presbyterian, one of the nation's most comprehensive, integrated academic healthcare systems. In keeping with NewYork-Presbyterian's long legacy of medical breakthroughs and innovation, Health Matters features the latest news, insights, and health tips from our trusted experts; inspiring first-hand accounts from patients and caregivers; and updates on the latest research and innovations in patient care, all in collaboration with our renowned medical schools, Columbia and Weill Cornell Medicine. To learn more visit: https://healthmatters.nyp.org
One of the most INSPIRING episodes on THE PICKLE JAR PODCAST. Amy Wood. CEO of the RAYMOND A. WOOD FOUNDATION shares the exciting and revolutionary development of a HOME SODIUM METER. Learn, share, support and be EMPOWERED knowing a home sodium meter is on the horizon for individuals battling the devastating and potentially life threatening consequences of sodium imbalance. WATCH HERE https://youtu.be/VcdUgBQpKAg LISTEN HERE APPLE. GOOGLE. SPOTIFY.VISIT THE WEBSITE https://www.rawoodfoundation.org/sodium-meter/ SHARE THE PODCAST Be part of the voice of changePOPULAR VIDEOS
In this episode, Lyell K. Jones Jr, MD, FAAN, speaks with Michael S. Okun, MD, FAAN, who served as the guest editor of the August 2025 Movement Disorders issue. They provide a preview of the issue, which publishes on August 1, 2025. Dr. Jones is the editor-in-chief of Continuum: Lifelong Learning in Neurology® and is a professor of neurology at Mayo Clinic in Rochester, Minnesota. Dr. Okun is the director at Norman Fixel Institute for Neurological Diseases and distinguished professor of neurology at University of Florida in Gainesville, Florida. Additional Resources Read the issue: continuum.aan.com Subscribe to Continuum®: shop.lww.com/Continuum Continuum® Aloud (verbatim audio-book style recordings of articles available only to Continuum® subscribers): continpub.com/Aloud More about the American Academy of Neurology: aan.com Social Media facebook.com/continuumcme @ContinuumAAN Host: @LyellJ Guest: @MichaelOkun Full episode transcript available here: Dr Jones: Our ability to move through the world is one of the essential functions of our nervous system. Gross movements like walking ranging down to fine movements with our eyes and our hands, our ability to create and coordinate movement is something many of us take for granted. So what do we do when those movements stop working as we intend? Today I have the opportunity to speak with one of the world's leading experts on movement disorders, Dr Michael Okun, about the latest issue of Continuum on Movement Disorders. Dr Jones: This is Dr Lyell Jones, Editor-in-Chief of Continuum. Thank you for listening to Continuum Audio. Be sure to visit the links in the episode notes for information about subscribing to the journal, listening to verbatim recordings of the articles, and exclusive access to interviews not featured on the podcast. Dr Jones: This is Dr Lyle Jones, Editor-in-Chief of Continuum: Lifelong Learning in Neurology. Today, I'm interviewing Dr Michael Okun, who is Continuum's guest editor for our latest issue on movement disorders. Dr Okun is the Adelaide Lackner Distinguished Professor of Neurology at the University of Florida in Gainesville, where he's also the director of the Norman Fixel Institute for Neurological Diseases. Dr Okun, welcome, and thank you for joining us today. Why don't you introduce yourselves to our listeners? Dr Okun: It's great to be here today. And I'm a neurologist. Everybody who knows me knows I'm pretty simple. I believe the patient's the sun and we should always orbit around the person with disease, and so that's how I look at my practice. And I know we always participate in a lot of research, and I've got a research lab and all those things. But to me, it's always the patients and the families first. So, it'll be great to have that discussion today. Dr Jones: Yeah, thank you for that, Dr Oaken. Obviously, movement disorders is a huge part of our field of neurology. There are many highly prevalent conditions that fit into this category that most of our listeners will be familiar with: idiopathic Parkinson's disease, essential tremor, tic disorders and so on. And having worked with trainees for a long time, it's one of the areas that I see a lot of trainees gravitate to movement disorders. And I think it's in part because of the prevalence; I think it's in part because of the diversity of the specialty with treatment options and DBS and Botox. But it's also the centrality of the neurologic exam, right? That's- the clinical examination of the patient is so fundamental. And we'll cover a lot of topics today with some questions that I have for you about biomarkers and new developments in the field. But is that your sense too, that people are drawn to just the old-fashioned, essential focus on the neurologic encounter and the neurologic exam? Dr Okun: I believe that is one of the draws to the field of movement. I think that you have neurologists from all over the world that are really interested and fascinated with what things look like. And when you see something that's a little bit, you know, off the normal road or off the normal beaten path… and we are always curious. And so, I got into movement disorders, I think, accidentally; I think even as a child, I was looking at people who had abnormal movements and tremors and I was very fascinated as to why those things happened and what's going on in the brain. And, you know, what are the symptoms and the signs. And then later on, even as my own career developed, that black bag was so great as a neurologist. I mean, it makes us so much more powerful than any of the other clinicians---at least in my biased opinion---out on the wards and out in the clinic. And, you know, knowing the signs and the symptoms, knowing how to do a neurological examination and really walking through the phenomenology, what people look like, you know, which is different than the geno- you know, the genotypes, what the genes are. What people look like is so much more important as clinicians. And so, I think that movement disorders is just the specialty for that, at least in my opinion. Dr Jones: And it helps bring it back to the patient. And that's something that I saw coming through the articles in this issue. And let's get right to it. You've had a chance to review all these articles on all these different topics across the entire field of movement disorders. As you look at that survey of the field, Dr Okun, what do you think is the most exciting recent development for patients with movement disorders? Dr Okun: I think that when you look across all of the different specialties, what you're seeing is a shift. And the shift is that, you know, a lot of people used to talk in our generation about neurology being one of these “diagnose and adios” specialties. You make the diagnosis and there's nothing that you can do, you know, about these diseases. And boy, that has changed. I mean, we have really blown it out of the water. And when you look at the topics and what people are writing about now and the Continuum issue, and we compare that the last several Continuum issues on movement disorders, we just keep accumulating a knowledge base about what these things look like and how we can treat them. And when we start thinking about, you know, all of the emergence of the autoimmune disorders and identifying the right one and getting something that's quite treatable. Back in my day, and in your day, Lyle, we saw these things and we didn't know what they were. And now we have antibodies, now we can identify them, we can pin them down, and we can treat many of them and really change people's lives. And so, I'm really impressed at what I see in changes in identification of autoimmune disorders, of channelopathies and some of the more rare things, but I'm also impressed with just the fundamental principles of how we're teaching people to be better clinicians in diseases like Parkinson's, Huntington's, ataxia, and Tourette. And so, my enthusiasm for this issue of Continuum is both on, you know, the cutting edge of what we're seeing based on the identification on our exams, what we can do for these people, but also the emergence of how we're shifting and providing much better care across a continuum for folks with basal ganglia diseases. Dr Jones: Yeah, I appreciate that perspective, Dr Okun. One of the common themes that I saw in the issue was with these new developments, right, when you have new tools like new diagnostic biomarker tools, is the question of if and when and how to integrate those into daily clinical practice, right? So, we've had imaging biomarkers for a while, DAT scans, etc. For patients with idiopathic Parkinson disease, one of the things that I hear a lot of discussion and controversy about are the seed amplification assays as diagnostic biomarkers. What can you tell us about those? Are those ready for routine clinical use yet? Dr Okun: I think the main bottom-line point for folks that are out there trying to practice neurology, either in general clinics or even in specialty clinics, is to know that there is this movement toward, can we biologically classify a disease? One of the things that has, you know, really accelerated that effort has been the development of these seed amplification assays, which---in short for people who are listening---are basically, we “shake and bake” these things. You know? We shake them for like 20 hours and we use these prionlike proteins, and we learn from diseases like prion disease how to kind of tag these things and then see, do they have degenerative properties? And in the case of Parkinson's disease, we're able to do this with synuclein. That is the idea of a seed amplification assay. We're able to use this to see, hey, is there synuclein present or not in this sample? And people are looking at things like cerebrospinal fluid, they're looking at things like blood and saliva, and they're finding it. The challenge here is that, remember- and one of the things that's great about this issue of Continuum is, remember, there are a whole bunch of different synucleinopathies. So, Dr Jones, it isn't just Parkinson's disease. So, you've got Parkinson's disease, you've got Lewy body, you know, and dementia with Lewy bodies. You've got, you know, multiple system atrophy is within that synucleinopathy, you know, group primary autonomic failure… so not just Parkinson's disease. And so, I think we have to tap the brakes as clinicians and just say, we are where we are. We are moving in that direction. And remember that a seed amplification assay gives you some information, but it doesn't give you all the information. It doesn't forgive you looking at a person over time, examining them in your clinic, seeing how they progress, seeing their response to dopamine- and by the way, several of these genes that are associated with Parkinson; and there's, you know, less than 20% of Parkinson is genetic, but several of these genes, in a solid third---and in some cases, in some series, even more---miss the synuclein assay, misses, you know, the presence of a disease like Parkinson's disease. And so, we have to be careful in how we interpret it. And I think we're more likely to see over time a gemish: we're going to smush together all this information. We're going to get better with MRIs. And so, we're actually doing much better with MRIs and AI-based intelligence. We've got DAT scans, we've got synuclein assays. But more than anything, everybody listening out there, you can still examine the person and examine them over time and see how they do over time and see how they do with dopamine. And that is still a really, really solid way to do this. The synuclein assays are probably going to be ready for prime time more in choosing and enriching clinical trials populations first. And you know, we're probably 5, 10 years behind where Alzheimer's is right now. So, we'll get there at some point, but it's not going to be a silver bullet. I think we're looking at these are going to be things that are going to be interpreted in the context for a clinician of our examination and in the context of where the field is and what you're trying to use the information for. Dr Jones: Thank you for that. And I think that's the general gestalt I got from the articles and what I hear from my colleagues. And I think we've seen this in other domains of neurology, right? We have the specificity and sensitivity issues with the biomarkers, but we also have the high prevalence of copathology, right? People can have multiple different neurodegenerative problems, and I think it gets back to that clinical context, like you said, following the patient longitudinally. That was a theme that came out in the idiopathic Parkinson disease article. And while we're on Parkinson disease, you know, the first description of that was what, more than two hundred years ago. And I think we're still thinking about the pathophysiology of that disorder. We understand risk factors, and I think many of our listeners would be familiar with those. But as far as the actual cause, you know, there's been discussion in recent years about, is there a role of the gut microbiome? Is this a prionopathic disorder? What's your take on all of that? Dr Okun: Yeah, so it's a great question. It's a super-hot area right now of Parkinson. And I kind of take this, you know, apart in a couple of different ways. First of all, when we think about Parkinson disease, we have to think upstream. Like, what are the cause and causes? Okay? So, Parkinson is not one disease, okay? And even within the genes, there's a bunch of different genes that cause it. But then we have to look and say, well, if that's less than 20% depending on who's counting, then 80% don't have a single piece of DNA that's closely associated with this syndrome. And so, what are we missing with environment and other factors? We need to understand not what happens at the end of the process, not necessarily when synuclein is clumping- and by the way, there's a lot of synuclein in the brains normally, and there's a lot of Tau in people's brains who have Parkinson as well. We don't know what we don't know, Dr Jones. And so when we begin to think about this disease, we've got to look upstream. We've got to start to think, where do things really start? Okay? We've got to stop looking at it as probably a single disease or disorder, and it's a circuit disorder. And then as we begin to develop and follow people along that pathway and continuum, we're going to realize that it's not a one-size-fits-all equation when we're trying to look at Parkinson. By the way, for people listening, we only spend two to three cents out of every dollar on prevention. Wouldn't prevention be the best cure, right? Like, if we were thinking about this disease. And so that's something that we should be, you know, thinking about. And then the other is the Global Burden of Disease study. You know, when we wrote about this in a book called Ending Parkinson's Disease, it looked like Parkinson's was going to double by 2035. The new numbers tell us it's almost double to the level that we expected in 2035 in this last series of numbers. So, it's actually growing much faster. We have to ask why? Why is it growing faster? And then we have lots of folks, and even within these issues here within Continuum, people are beginning to talk about maybe these environmental things that might be blind spots. Is it starting in our nose? Is it starting in our gut? And then we get to the gut question. And the gut question is, if we look at the microbiomes of people with Parkinson, there does seem to be, in a group of folks with Parkinson, a Parkinson microbiome. Not in everyone, but if you look at it in composite, there seems to be some clues there. We see changes in Lactobacillus, we see some bacteria going up that are good, some bacteria going down, you know, that are bad. And we see flipping around, and that can change as we put people on probiotics and we try to do fecal microbiota transplantations- which, by the way, the data so far has not been positive in Parkinson's. Doesn't mean we might not get there at some point, but I think the main point here is that as we move into the AI generation, there are just millions and millions and millions of organisms within your gut. And it's going to take more than just our eyes and just our regular arithmetic. You and I probably know how to do arithmetic really well, but this is, like, going to be a much bigger problem for computers that are way smarter than our brains to start to look and say, well, we see the bacteria is up here. That's a good bacteria, that's a good thing or it's down with this bacteria or this phage or there's a relationship or proportion that's changing. And so, we're not quite there. And so, I always tell people---and you know, we talk about the sum in the issue---microbiomes aren't quite ready for prime time yet. And so be careful, because you could tweak the system and you might actually end up worse than before you started. So, we don't know what we don't know on this issue. Dr Jones: And that's a great point. And one of the themes they're reading between the lines is, we will continue to work on understanding the bio-pathophysiology, but we can't wait until that day to start managing the risk factors and treating patients, which I think is a good point. And if we pivot to treatment here a little bit, you know, one of the exciting areas of movement disorders---and really neurology broadly, I think movement disorders has led the field in many ways---is bioelectronic therapy, or what one of my colleagues taught me is “electroceutical therapy”, which I think is a wonderful term. Dr Okun, when our listeners are hearing about the latest in deep brain stimulation in patients who have movement disorders, what should they know? What are the latest developments in that area with devices? Dr Okun: Yeah. So, they should know that things are moving rapidly in the field of putting electricity into the brain. And we're way past the era where we thought putting a little bit of electricity was snake oil. We know we can actually drive these circuits, and we know that many of these disorders---and actually, probably all of the disorders within this issue of Continuum---are all circuit disorders. And so, you can drive the circuit by modulating the circuit. And it's turned out to be quite robust with therapies like deep brain stimulation. Now, we're seeing uses of deep brain stimulation across multiple of these disorders now. So, for example, you may think of it in Parkinson's disease, but now we're also seeing people use it to help in cases where you need to palliate very severe and bothersome chorea and Huntington's disease, we're seeing it move along in Tourette syndrome. We of course have seen this for various hyperkinetic disorders and dystonias. And so, the main thing for clinicians to realize when dealing with neuromodulation is, take a deep breath because it can be overwhelming. We have a lot of different devices in the marketplace and no matter how many different devices we have in the marketplace, the most important thing is that we get the leads. You know, where we're stimulating into the right location. It's like real estate: location, location, location, whether you've got a lead that can steer left, right, up, down and do all of these things. Second, if you're feeling overwhelmed because there are so many devices and so many settings, especially as we put these leads in and they have all sorts of different, you know, nodes on them and you can steer this way and that way, you are not alone. Everybody is feeling that way now. And we're beginning to see AI solutions to that that are going to merge together with imaging, and then we're moving toward an era of, you know, should I say things like robotic programming, where it's going to be actually so complicated as we move forward that we're going to have to automate these systems. There's no way to get this and scale this for all of the locales within the United States, but within the entire world of people that need these types of devices and these therapies. And so, it's moving rapidly. It's overwhelming. The most important thing is choosing the right person. Okay? For this, with multidisciplinary teams, getting the lead in the right place. And then all these other little bells and whistles, they're like sculpting. So, if you think of a sculpture, you kind of get that sculpture almost there. You know, those little adds are helping to maybe make the eyes come out a little more or the facial expression a little bit better. There's little bits of sculpting. But if you're feeling overwhelmed by it, everybody is. And then also remember that we're starting to move towards some trials here that are in their early stages. And a lot of times when we start, we need more failures to get to our successes. So, we're seeing trials of people looking at, like, oligo therapies and protein therapies. We're seeing CRISPR gene therapies in the laboratory. And we should have a zero tolerance for errors with CRISPR, okay? we still have issues with CRISPR in the laboratory and which ones we apply it to and with animals. But it's still pretty exciting when we're starting to see some of these therapies move forward. We're going to see gene therapies, and then the other thing we're going to see are nano-therapies. And remember, smaller can be better. It can slip across the blood brain barrier, you have very good surface area-to-volume ratios, and we can uncage drugs by shining things like focused ultrasound beams or magnets or heat onto these particles to turn them on or off. And so, we're seeing a great change in the field there. And then also, I should mention: pumps are coming and they're here. We're getting pumps like we have for diabetes and neurology. It's very exciting. It's going to be overwhelming as everybody tries to learn how to do this. So again, if you're feeling overwhelmed, so am I. Okay? But you know, pumps underneath the skin for dopamine, pumps underneath the skin for apomorphine. And that may apply to other disorders and not just Parkinson as we move along, what we put into those therapies. So, we're seeing that age come forward. And then making lesions from outside the brain with focused ultrasound, we're starting to get better at that. Precision is less coming from outside the brain; complications are also less. And as we learn how to do that better, that also can provide more options for folks. So, a lot of things to read about in this issue of Continuum and a lot of really interesting and beyond, I would say, you know, the horizon as to where we're headed. Dr Jones: Thank you for that. And it is a lot. It can be overwhelming, which I guess is maybe a good reason to read the issue, right? I think that's a great place to end and encourage our listeners to pick up the issue. And Dr Okun, I want to thank you for joining us today. Thank you for such a great discussion on movement disorders. I learned a lot. I'm sure our listeners will as well, given the importance of the topic, your leadership in the field over many years. I'm grateful that you have put this issue together. So, thank you. And you're a busy person. I don't know how we talked you into doing this, but I'm really glad that we did. Dr Okun: Well, it's been my honor. And I just want to point out that the whole authorship panel that agreed to write these articles, they did all the work. I'm just a talking head here, you know, telling you what they did, but they're writing, and the people that are in the field are really, you know, leading and helping us to understand, and have really put it together in a way that's kind of helped us to be better clinicians and to impact more lives. So, I want to thank the group of authors, and thank you, Dr Jones. Dr Jones: Again, we've been speaking with Dr Michael Okun, guest editor of Continuum's most recent issue on movement disorders. Please check it out. And thank you to our listeners for joining today. Dr Monteith: This is Dr Teshamae Monteith, Associate Editor of Continuum Audio. If you've enjoyed this episode, you'll love the journal, which is full of in-depth and clinically relevant information important for neurology practitioners. Use the link in the episode notes to learn more and subscribe. Thank you for listening to Continuum Audio.
August is shaping up to be a game of disease whack-a-mole. Recent heat and rain in the Central Corn Belt have fueled Southern Rust development, but the upcoming cool-down looks ideal for tar spot. Are you prepared to manage it all? On this week's podcast, Wyffels Agronomy Managers Eric Wilson and Jared Goplen talk about late summer disease threats, and touch on the impact of recent storms. Now's the perfect time to scout for disease and assess fungicide needs.Links discussed in this episode:Crop Protection Network - Fungicide Efficacy Between the Rows® - Southern RustBetween the Rows® - Tar SpotBetween the Rows® - Damage from Summer StormsWe want to hear from you. Have questions you want us to address on future episodes? Ideas for how we can make this better? Email us at agronomy@wyffels.com. Wyffels Hybrids. Fiercely independent, and proud of it.
For many people in recovery, there is a specific moment in time they can point to when their lives turn around. At that moment, life one becomes life two. Dr. Robb Kelly discuss that moment in his life and how life two has led him to a career of helping people. Robb Kelly was born in Manchester, England, into a family that had a history of alcoholism. He obtained his Doctorate in Psychology from Oxford and is now the founder of The Robb Kelly Recovery Group, in addition to being an accomplished author and internationally sought-out speaker. The Robb Kelly Recovery Group and all of their services can be reached at https://robbkelly.com/ The State of Wisconsin's Dose of Reality campaign is at https://www.dhs.wisconsin.gov/opioids/index.htm More information about the federal response to the ongoing opiate crisis can be found at https://www.dea.gov/onepill The views and opinions of the guests on this podcast are theirs and theirs alone and do not necessarily represent those of the host or Westwords Consulting. We're always interested in hearing from individuals or organizations who are working in substance use disorder treatment or prevention, mental health care and other spaces that lift up communities. This includes people living those experiences. If you or someone you know has a story to share or an interesting approach to care, contact us today! Follow us on Facebook, LinkedIn, and YouTube. Subscribe to Our Email List to get new episodes in your inbox every week!
In this podcast we share a few selected highlights from the Alzheimer's Association International Conference (AAIC) day two and day three of the main event in Toronto and Online, 27the - 31st July. -- Dr Connor Richardson, NIHR / Alzheimer's Society Dem Comm Research Fellow from University of Newcastle hosts the show with special guests: Sára Zsadányi, PhD Student at Sant Pau Memory Unit – Neuroimaging Core and Universitat Autonoma de Barcelona Dr Tatiana Giovannucci, Alzheimer's Association Research Fellow Dr Richard Oakley, Associate Director of Research at Alzheimer's Society The AAIC brings together distinguished basic scientists, clinical researchers, early career investigators, clinicians and the care research community at the largest and most influential international conference on dementia science. They share theories and breakthroughs while exploring opportunities to accelerate work and elevate careers. -- Main plenary talks from the day came from Professor Inhee Mook-Jung Seoul National University, Korea with a talk titled "The Gut-Brain Axis in Alzheimer's Disease: Unraveling Pathogenesis and Exploring Novel Therapeutic Strategies" and Dr Juan Fortea, Memory Unit Director — Hospital de la Santa Creu i Sant Pau, Spain with a talk titled "Alzheimer's Disease in Down Syndrome". @alzassociation #aaic25 #aaic -- Find more information on our guests, and a full transcript of this podcast on our website at: https://www.dementiaresearcher.nihr.ac.uk/podcast -- The views and opinions expressed by guests in this podcast represent those of the guests and do not necessarily reflect those of NIHR Dementia Researchers, PIA membership, ISTAART or the Alzheimer's Association.
This week, Dr. Kahn discussed a new paper about the power of a Zero Score Calcium CT Scan in people without symptoms but concerns for soft plaque (non-calcified) in those with symptoms. Generally, patients with symptoms are better tested by Coronary CT Angiograms (CCTA), optimally with FFR and Cleerly Software analysis. He provides case studies from the clinic. Other topics include plant diets for Crohn's Disease prevention, the goal of 7,000 steps a day, Lipoprotein(a) and stroke, heart and brain risk control benefits, strategies to avoid weight gain, and erythritol and heart disease. Thanks to Igennus.com and the discount code DrKahn.
On July 22, 2025, we lost Birmingham-born rock vocalist and cultural icon Ozzy Osbourne, rock's "prince of darkness," at the age of 76. His death, from complications due to Parkinson's Disease, ends a career spanning five decades, in which he pioneered an entire subgenre of heavy metal music, as frontman for Black Sabbath, before going on to an even bigger career as a solo artist, where he is credited for introducing the guitarist Randy Rhoads to the wider rock world, and for creating the wildly popular Ozzfest tours. Then, when he'd done it all, he and members of his family, Jack, Kelly, and his manager-wife Sharon, became pioneers of "reality TV" with the hit series, The Osbournes. On this very special episode, we hear two personal stories of how Ozzy's music and persona touched the lives of music industry professionals who were also, first and foremost, fans. Returning to our program, Jenn D'Eugenio (Women In Vinyl), made the journey to Birmingham for Ozzy's bittersweet Back To The Beginning farewell show, . She shares her first-hand descriptions of the event, plus two other fascinating Black Sabbath stories. Also returning is acclaimed music journalist Sylvie Simmons (Sounds, Kerrang!, and more), who took some time away from writing an Ozzy piece for Mojo magazine to share some personal anecdotes with Ozzy dating all the way back to his last days in Sabbath and how Sharon navigated his career back to the top. The Record Store Day Podcast is a weekly music chat show written, produced, engineered and hosted by Paul Myers, who also composed the theme music and selected interstitial music. Executive Producers (for Record Store Day) Michael Kurtz and Carrie Colliton. For the most up-to-date news about all things RSD, visit RecordStoreDay.com Please consider subscribing to our podcast wherever you get podcasts, and tell your friends, we're here every week and we love making new friends.
Long-Term Knee Health in Adults with a History of Adolescent Osgood-Schlatter: A National Cohort Study of Patients in Secondary Care in Denmark 1977-2020 Krommes K, Bjerre A, Thorborg K, et al. Sports Med. Published Ahead of Print. doi:10.1007/s40279-025-02214-5 Due to copyright laws, unless the article is open source we cannot legally post the PDF on the website for the world to download at will. Brought to you by our sponsors at: CSMi – https://www.humacnorm.com/ptinquest Learn more about/Buy Erik/Jason/Chris's courses – The Science PT Support us on the Patreons! Music for PT Inquest: “The Science of Selling Yourself Short” by Less Than Jake Used by Permission Other Music by Kevin MacLeod – incompetech.com: MidRoll Promo – Mining by Moonlight Koal Challenge – Sam Roux
In part seven of this ten-part series, Dr. Paul Crane and Dr. Prashanth Ramachandran discuss how to counsel patients about getting care abroad. Show reference: https://academic.oup.com/cid/article/78/6/1554/7280488
A collection of lab-reared mosquitoes were dumped on Hawaii in June 2025. In 2008 the Gates Foundation paid Jichi Medical University $100,000 “to design a mosquito that can produce and secrete a malaria vaccine protein into a host's skin.” In 2010 Science Magazine online called these mosquitoes “flying vaccinators.” Years later genetically modified mosquitos were released in California and Florida, along with countries like Brazil. The reasoning varies: to stop invasive species, to breed away disease carriers, and to prevent malaria. But when you introduced modified species into a local population then you are introducing invasive species. When you try to limit population numbers you could end up killing all the local population. These experiments have all but failed completely. Besides, Malaria has a standard set of symptoms and most cases in the US and even Japan are from Africa, Southern Asia, and South America. There are virtually no domestic cases and so we know that mosquitos and bacteria do not cause malaria. So what's the point in releasing engineered insects? Perhaps it has something to do with black magic. The Japanese KODOKU and Chinese GU systems of magic involve the use of insects to inflict harm or obtain protection. Poisonous and venomous insects are placed in a container where they fight and die. The last surviving insect is then used to create poisons or protective charms. Consider this: genetically modified insects are released in large contained areas to fight insects carrying serious diseases. They are intended to kill off the local insect populations, at which point the invasive modified insect can be used to inject proteins into the local human population. In other words, this isn't just mad science, it's KODOKU.*The is the FREE archive, which includes advertisements. If you want an ad-free experience, you can subscribe below underneath the show description.FREE ARCHIVE (w. ads)SUBSCRIPTION ARCHIVEX / TWITTER FACEBOOKWEBSITECashApp: $rdgable EMAIL: rdgable@yahoo.com / TSTRadio@protonmail.comBecome a supporter of this podcast: https://www.spreaker.com/podcast/the-secret-teachings--5328407/support.
BEST OF TSTSHOW 1: In 2008 the Bill and Melinda Gates Foundation financed Jichi Medical University in Japan to develop “a mosquito that can produce and secrete a malaria vaccine protein.” The initiative was aimed at creating a “flying syringe, to deliver protective vaccine via saliva.” In 2010 they gave money to UK-based biotech company Oxitec to develop genetically modified mosquitoes that could be lethal to carriers of dengue, zika, and yellow fever. Science Magazine published a report that year on this Japanese research and discussed what they called “flying vaccinators.” In 2015 the people of Florida, set to be the Oxitec testing ground, signed a petition against such open-air lab trials. In 2021 the trial proceeded regardless and in April 2022 Nature published a report on the results which found that although mosquitoes died in large numbers there was no reduction in disease spread or need for pesticides, which often cause the very symptoms of the diseases. A few days ago a mosquito-malaria-vaccine trial was carried out in Washington State. Of 14 participants, 7 were diagnosed with malaria leading researchers to declare their mosquito-vaccine was 50% effective. However, they made no mention of how the other half of the group could be exposed to ‘malaria' and yet not develop the disease with its vague ‘symptom complex' list. There is no question why such a malaria vaccine should be tested in the U.S. where cases rarely top 2,000 and where death rarely reaches double digits. Meanwhile, Africa is home to 95% of cases and 96% of deaths, while India is home to most of the world's polio. It is likely these ‘disease' are caused by environment, as demonstrated by official WHO data, rather than tiny invisible particles. While focus has been on the mosquito, the NIH and B&MGF have also been researching a needle-less vaccine. Such research goes back to Spain in 1999 where researchers were able to spread vaccine-induced antibodies to non-vaccinated rabbits via vaccinated rabbits. All was done in natural interaction without needle, misquotes, or any other tool. SHOW 2: Malaria is supposedly on the rise in the United States, where seven cases between Florida and Texas have been reported in the last few weeks. The CDC issued a public health alert as a result and the media collectively is spreading the terror of malaria with graphs, charts, stories, and symptoms. The strange thing is that malaria is always present, particularly in those two states, where in 2012 cases were 102 in Texas and 59 in Florida. Over the years those numbers went up and down, peaking in 2019 and then dropping significantly in 2020. This is why the media can claim cases are on the rise even if they are below the previous decade peak. From NPR to the New Scientist there are, of course, solutions to this terrible outbreak that isn't much of an outbreak: vaccines and genetically modified mosquitoes that could produce antibodies against malaria parasite. However, these same genetically modified insects have been in development since 2008 and were released in Florida after 2015. They were created with money from the B&MGF: “a mosquito that can produce and secrete a malaria vaccine protein.” But what if gm-mosquitoes are another alternative lab-leak theory? Malaria's symptoms are themselves invariably described in the same way that heat stroke symptoms are: headaches, fever, muscle aches, nausea, etc. Any mosquito issue, genetically modified or otherwise, can of course be treated with new drugs and chemicals, like the Pyriproxyfen that caused Microcephaly which was blamed on zika and mosquitos. *The is the FREE archive, which includes advertisements. If you want an ad-free experience, you can subscribe below underneath the show description.FREE ARCHIVE (w. ads)SUBSCRIPTION ARCHIVEX / TWITTER FACEBOOKWEBSITECashApp: $rdgable EMAIL: rdgable@yahoo.com / TSTRadio@protonmail.comBecome a supporter of this podcast: https://www.spreaker.com/podcast/the-secret-teachings--5328407/support.
Sanitary towels morph into test stripsThis episode was brought to you by Mouser, our favorite place to get electronics parts for any project, whether it be a hobby at home or a prototype for work. Click HERE to learn more about quantum dots and how their fluorescent properties can be used for various applications! Become a founding reader of our newsletter: http://read.thenextbyte.com/ As always, you can find these and other interesting & impactful engineering articles on Wevolver.com.
Listeria in Livestock Equine Infectious Anemia and West Nile Virus Dairy's Impact on the State's Economy 00:01:05 – Listeria in Livestock: Beginning today's show is A.J. Tarpoff, K-State Extension beef veterinarian, and Jason Warner, K-State cow-calf Extension specialist, as they explain listeria and what is a common cause of it for livestock. 00:12:05 – Equine Infectious Anemia and West Nile Virus: Kansas animal health commissioner, Justin Smith, continues the show as he discusses equine infectious anemia and West Nile virus for horses as the diseases have recently been reported in Kansas. agriculture.ks.gov 00:23:05 – Dairy's Impact on the State's Economy: Mike Brouk, K-State dairy specialist, concludes today's show as he looks at the impact the Kansas dairy industry has on the state's economy. Send comments, questions or requests for copies of past programs to ksrenews@ksu.edu. Agriculture Today is a daily program featuring Kansas State University agricultural specialists and other experts examining ag issues facing Kansas and the nation. It is hosted by Shelby Varner and distributed to radio stations throughout Kansas and as a daily podcast. K‑State Research and Extension is a short name for the Kansas State University Agricultural Experiment Station and Cooperative Extension Service, a program designed to generate and distribute useful knowledge for the well‑being of Kansans. Supported by county, state, federal and private funds, the program has county Extension offices, experiment fields, area Extension offices and regional research centers statewide. Its headquarters is on the K‑State campus in Manhattan
A quick breakdown of public health jargon in under five minutes that is made for curious minds.
Sabaidee! Today, travel medicine specialists Drs. Paul Pottinger ("Germ") & Chris Sanford ("Worm") answer your travel health questions:What's up with flesh-eating disease on Florida beaches?What is the role of AI in travel health?I'm 56--should I get the RSV vaccine?What mosquito-borne infections might I have just contracted in Washington State?Do you believe trekking poles are beneficial?What is Global Entry, and is it worth it?What is antimicrobial resistance?We hope you enjoy this podcast! If so, please follow us on the socials @germ.and.worm, subscribe to our RSS feed and share with your friends! We would so appreciate your rating and review to help us grow our audience. And, please send us your questions and travel health anecdotes: germandworm@gmail.com.Our Disclaimer: The Germ and Worm Podcast is designed to inform, inspire, and entertain. However, this podcast does NOT establish a doctor-patient relationship, and it should NOT replace your conversation with a qualified healthcare professional. Please see one before your next adventure. The opinions in this podcast are Dr. Sanford's & Dr. Pottinger's alone, and do not necessarily represent the opinions of the University of Washington or UW Medicine.
Red light therapy delivers scientifically-backed benefits that transform aging, thyroid function, autoimmune responses, and cognitive performance. In this episode, I'll reveal how red light therapy optimizes your mitochondria health to fuel cellular energy production throughout your body, creating measurable improvements in overall health. Discover the most effective red light therapy devices and proven protocols that maximize your results. Listen now! ✅Start healing with us! Learn more about our virtual clinic: https://drruscio.com/virtual-clinic/ ⚡Featured red light products: https://platinumtherapylights.com/products/biomax-rlt https://boncharge.com/products/red-light-face-mask https://www.capillus.com/collections/all-caps https://hairmax.com/products/laserband-82-comfortflex https://novaalab.com/products/new-red-light-therapy-pad-at-home https://novaalab.com/products/novaa-extra-strength-healing-laser-new-template https://shop.baumanmedical.com/products/lasercap-as-seen-on-tv-dr-bauman-on-the-doctors https://kineon.io/products/red-light-therapy-device https://www.vielight.com/devices/
In part six of this ten-part series, Dr. Paul Crane and Dr. Prashanth Ramachandran discuss findings from a recent systematic review on pneumococcal meningitis, including the role of corticosteroid, the importance of treatment timing, and emerging adjunctive therapies that may improve patient outcomes. Show reference: https://academic.oup.com/braincomms/article/6/3/fcae131/7644484
In 2004, Madelaine Weiss had a flesh-eating disease, which started as strep throat and extended into her arm. She had a 1% chance of survival. The doctors were threatening to remove her upper right quadrant, but after seven weeks in the hospital and three months off her post at Harvard Medical School, here she is – happy, healthy, prosperous, and productive with a smile. Madelaine Weiss is a Harvard-trained licensed psychotherapist and mindset expert, with an MBA and board certification in executive, career, and life coaching. She is the founder and former chair of The School-Business Partnership, former parenting education facilitator, group mental health practice administrative director, corporate chief organizational development officer, associate director of an educational resource program at Harvard Medical School, and bestselling author of “Getting to G.R.E.A.T. 5-Step Strategy for Work and Life.” "The harder a decision is to make..... STOP and take time to listen to your inner voice." Madelaine shares her full story in her interview and points you to building your best adventures in life. I"A great life depends on a great fit between who we are and the environments in which we work and live." Getting to G.R.E.A.T. is a lively, practical guidebook for living with a proven method that has already changed so many lives. Loaded with science and stories, each information-packed chapter launches with a topic-relevant vignette from the author's own experience, moves to research and practical recommendations on each chapter topic, and concludes with a chapter-specific case example and exercise for personal use. Beginning with the pivotal event that shaped the trajectory of her work and life, Madelaine Weiss reveals a powerfully effective five-step strategy for satisfaction and success in your own work and life. DIVE INTO A WORLD WHERE YOU AND YOUR BRAIN TEAM UP TO BUILD THE STORIES OF YOUR LIFE!
Topics explored in this episode include:The Nervous System through the lens of Polyvagal TheoryHow to expand your Window of Wellness & ResilienceThe impact of lonelinessTrauma healing & addiction recoveryCo-regulation & the power of communityPractices for Vagal ToningDr. Ilene Naomi Rusk received her PhD in Psychology (Neuropsychology and Psychopharmacology) in the UK with a focus on the brain circuitry involved in appetite regulation, motivation, and satiation. In Canada she completed fellowships in neuroscience + neuropsychology looking at novel treatment strategies for Alzheimer's Disease and neuropsychiatric issues. Dr Rusk was the Parkinson's Disease Fellow for Canada and she worked collaboratively with pharmaceutical companies authoring numerous peer-reviewed articles in neuroscience & treating brain and behavior disorders. She is trained in somatic approaches to healing trauma and nervous system disorders, and uses numerous trauma resolution techniques (EMDR and Brainspotting, among them). Training in cognitive rehabilitation adds to her healing repertoire. Dr Rusk's extensive trainings in Polyvagal Theory has led her incorporate vagal toning into her work with patients with anxiety, depression and stress sensitivities. She draws from decades of experience in ancestral healing, yoga, breathwork + mindfulness practices and uses them as an integral part of her functional nervous system health program. Spiritual guidance is intrinsic to her work.Dr. Rusk co-founded the Brain and Behavior Clinic in Boulder, CO and developed the Healthy Brain Program. While training in a functional medicine approach to cognitive + emotional health, she developed a team-based program to integrate functional and personalized brain health with trauma healing work to optimize stress resilience, anxiety and mental health. She is former Director of Community Medical Education for Grillo Health Information Resource Center and the Director of Resilience Training with Disaster Resources an international organization dedicated to healing anxiety, stress + distress in educators, children and families after natural and man-made disasters. Dr. Rusk's work focuses on blending personalized integrative healthcare and psychological wellness within a scientist-practitioner model. She has woven spirituality and mindfulness into her practice for over 35 years, and leads monthly online Embodied Brain Polyvagal Groups. To learn more & join Dr Rusk's next Vagal Toning Practice Group visit: https://www.ilenenaomirusk.com/events__Access a free mindfulness meditation guided by Mary Tilson to help manage cravings and regulate emotions: https://pages.sunandmoonsoberliving.com/easemeditationFollow along on Instagram: @sunandmoon.soberliving __Disclaimer: The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment.
Which of the following best describes a disease that should be reported to the local or regional public health department? A. Diseases where public health intervention is needed to help prevent spread to the region or community. B. Diseases with significant rates of mortality and morbidity. C. Diseases that are most often noted among individuals with significant immunocompromise. D. Diseases where intervention in early life helps lead to improved health in adulthood. ---YouTube: https://www.youtube.com/watch?v=oBvF5QT9RQE&list=PLf0PFEPBXfq592b5zCthlxSNIEM-H-EtD&index=120Visit fhea.com to learn more!
A spokesman for former Gov. Andrew Cuomo pointed to a pilot program he announced in 2013 that invested $25 million to add 5,000 Universal pre-K seats. Plus, the New York City Health Department is investigating a cluster of Legionnaires' disease in central Harlem. Also, 311 complaints about dog waste on sidewalks have gone up every year since the pandemic. And finally, a mid-season check in on the defending WNBA champion New York Liberty.
7-28 Adam and Jordana 10a hour
Could gene therapy with neurotrophic factors help restore dopaminergic terminals in Parkinson's disease? Dr. Michele Matarazzo speaks with Dr. Amber Van Laar about her team's Phase 1b trial of AAV2–GDNF gene therapy delivered directly to the putamen. They discuss the preclinical evidence for GDNF, how advanced delivery techniques and higher putamen coverage may overcome past challenges, and the encouraging early results in moderate Parkinson's. The conversation also explores lessons from previous trials, safety outcomes, and the path forward. Read the article.
The modern phenomena of Doomscrolling and its affect on Huntington's Disease. A short monologue.
Message by Pastor J.J. Stanbridge Text: Matthew 6:25-34 The post Disease of the Heart appeared first on Flint Hill Baptist Church.
In this episode, we review the high-yield topic Frontotemporal Dementia (Pick Disease) from the Neurology section at Medbullets.comFollow Medbullets on social media:Facebook: www.facebook.com/medbulletsInstagram: www.instagram.com/medbulletsofficialTwitter: www.twitter.com/medbulletsLinkedin: https://www.linkedin.com/company/medbullets
A short monologue concerning the possible use of nicotine patches for Huntington's Disease.
Man's deadliest predator takes more than a million lives each year and is no bigger than your fingernail. To mark mosquito season, history professor Dr. Timothy Winegard sits down with Dr. Sanjay Gupta to unpack how we can use lessons from the past to fight mosquitoes in the future. Plus, find out how you can make your blood a little less appetizing. Learn more about your ad choices. Visit podcastchoices.com/adchoices
It's Friday, July 25th, A.D. 2025. This is The Worldview in 5 Minutes heard on 140 radio stations and at www.TheWorldview.com. I'm Adam McManus. (Adam@TheWorldview.com) By Adam McManus Victory for Dutch homeschool families Earlier this year, the Home School Legal Defense Association highlighted the story of the Hinrich Family, who fought for over a year for the right to homeschool their children in the Netherlands. Just this month, the Public Prosecutor's Office publicly stated that parents who refuse to send their children to compulsory school, based on a qualified religious objection, will no longer be prosecuted. Like the Hinrichs, over 2,100 children were exempt from compulsory attendance in 2024 in the Netherlands, due to objections by their parents that no school in their area reflected their religious convictions. This is one of the lawful reasons to homeschool in the country. Nevertheless, parents were criminally prosecuted for truancy and found themselves, as did the Hinrichs, in a court battle to defend their natural right to raise their children according to their religious convictions. Thankfully, this decision changes that. The Public Prosecutor reported there were 160 criminal cases against parents in 2024. These prosecutions occurred despite Article 18 of the International Covenant on Civil and Political Rights, which requires states, including the Netherlands, to respect “the liberty of parents…to ensure the religious and moral education of their children in conformity with their own convictions.” Please pray that the authorities in the Netherlands will stop harassing homeschoolers for good. Deuteronomy 6:4-7 underscores the role parents should play in the education of their children. “Hear, O Israel: The Lord our God, the Lord is one. Love the Lord your God with all your heart and with all your soul and with all your strength. These commandments that I give you today are to be on your hearts. Impress them on your children. Talk about them when you sit at home and when you walk along the road, when you lie down, and when you get up.” Epstein files controversy dragging Trump presidency down The Epstein files controversy is dragging down the Trump presidency. Gallup reports that his approval rating has sunk to 37%. The revolt of House Republicans who favor releasing the Epstein case documents surprised White House officials and multiple members of GOP leadership, reports Politico.com. Some have questioned whether President Trump himself is implicated criminally. In an interview with Major Garrett on CBS' The Takeout, House Speaker Mike Johnson emphasized the need to be transparent. JOHNSON: “We want full transparency. We want everybody who is involved in any way with the Epstein evils -- let's call it what it was -- to be brought to justice as quickly as possible. We want the full weight of the law on their heads.” GARRETT: “But when the Justice Department said in that same two-page memo, there's no reason to pursue further prosecutions, many said, ‘How can those two things be properly aligned?'” JOHNSON: “These are good questions. I don't know. I've never seen the Epstein evidence. It wasn't in my lane, but I have the same concern and question that a lot of people do. I mean, there are real victims here.” Murder victim's mother forgives murderer Bryan Kohberger Bryan Kohberger, who admitted to brutally stabbing four University of Idaho students to death at their home in November 2022, was given his sentence on July 23rd. Sadly, the judge sidestepped Biblical justice found in Genesis 9:6 which says, “Whoever sheds the blood of man, by man shall his blood be shed; for in the image of God has God made mankind." The judge gave Kohberger four consecutive sentences of life in prison without the possibility of parole. He was also ordered to pay a combined $200,000 in fines and $5,000 in civil penalties to the families of each victim. He was also sentenced to an additional 10 years in prison and ordered to pay a $50,000 fine in connection with a count of burglary associated with the crime. Amazingly, the mother of one of Bryan Kohberger's murder victims forgave her daughter's killer in court Wednesday, expressing hope that he would find Jesus Christ and said she'd be praying for him. Cara Northington, the mother of murder victim Xana Kernodle, expressed confidence that “Our Lord and Savior, Jesus Christ, now has her in His loving arms in Heaven, where she can never be harmed ever again for eternity.” “Ozzy” Osbourne, who championed hell, wanted to go to Heaven And finally, "Ozzy" Osbourne, who rose to prominence during the 1970s as the lead vocalist of the heavy metal band Black Sabbath, died on July 22nd at the age of 76, reports The Guardian. The English musician adopted the nickname "Prince of Darkness.” Osbourne's signature song entitled “Black Sabbath” included these lyrics: “What is this that stands before me? Figure in black which points at me Turn 'round quick, and start to run Find out I'm the chosen one.” In their 1970 song entitled “N.I.B.”, they feature the lyrics, “My name is Lucifer, please take my hand.” And a 1980 song entitled “Mr. Crowley” referenced Aleister Crowley, an English occultist often labeled as "the wickedest man in the world." Ozzy explored Crowley's legacy with curiosity and mystique. The lyrics said, “Mr. Crowley, what went on in your head? Oh Mr. Crowley, did you talk to the dead?” Osbourne sold over 100 million albums, including his solo work and Black Sabbath releases. He was inducted into the Rock and Roll Hall of Fame as a member of Black Sabbath in 2006 and as a solo artist in 2024. In the early 2000s, Osbourne became a reality television star when he appeared in the degrading, profanity-filled MTV reality show The Osbournes. It aired from 2002 to 2005 alongside Sharon, his second wife, and two of their children, Kelly and Jack. Sadly, Osbourne abused alcohol and drugs most of his life. He also was diagnosed with Parkinson's Disease in his twilight years. For someone who championed hell, he appeared to want to go to Heaven. In a 2010 interview with The Sunday Times, he said, “I genuinely believe that if you're a good person, you go to Heaven. But I can't imagine what that is. There has to be more to life than this.” There is indeed more to life than what we can see in the physical realm. But, in Romans 3:10, the Bible says, “There is none righteous, no, not one.” And Isaiah 64:6 says, “All our righteousness is like filthy rags.” Finally, Romans 10:9 proclaims, “If you declare with your mouth, ‘Jesus is Lord,' and believe in your heart that God raised Him from the dead, you will be saved.” If you've never repented of your sin and asked Jesus Christ to be your Savior and Lord, there is no time like the present. Close And that's The Worldview on this Friday, July 25th, in the year of our Lord 2025. Follow us on X or subscribe for free by Spotify, Amazon Music, or by iTunes or email to our unique Christian newscast at www.TheWorldview.com. Plus, you can get the Generations app through Google Play or The App Store. I'm Adam McManus (Adam@TheWorldview.com). Seize the day for Jesus Christ.
As a young man, Jerry Sargeant was caught up in crime and heading down a dark path. Then a car accident changed everything. It was a wake-up call that sparked a spiritual awakening and set him on a new journey: one focused on healing, growth, and helping others.In this episode of the Align Podcast, Jerry Sargeant, founder of Star Magic Healing, shares powerful insights on trauma, disease, and the secret forces that affect our health. From shadow parasites to energy healing techniques, Jerry discusses how we can unlock deeper awareness and self-healing. He even performs a live healing on Aaron and shares actionable ways to clear stagnant energy from our bodies and spaces.OUR GUESTJerry Sargeant, widely known as ‘The Facilitator', is an acclaimed global Trainer for Healing Facilitators of all levels, author and a renowned Frequency Healer celebrated for his extraordinary abilities. Born in 1978 in Cheltenham, UK. Through the creation of Star Magic Healing, an unparalleled holistic approach that merges subtle energy, frequency, quantum physics, visualization and intention, Jerry has become a catalyst for transformation on physical, emotional, mental, and spiritual planes. His groundbreaking techniques have gained worldwide recognition and established Star Magic Healing as a leading modality since its inception in 2016.Jerry's mission transcends borders and touches the lives of countless individuals. His profound healing techniques, straightforward guidance, and unyielding devotion to empowering others propel him on a journey to create a world where every individual embraces their inherent power and shapes their destiny.JERRY SARGEANT
Joe's Premium Subscription: www.standardgrain.comGrain Markets and Other Stuff Links-Apple PodcastsSpotifyTikTokYouTubeFutures and options trading involves risk of loss and is not suitable for everyone.0:00 Farm Bankruptcies Rise4:57 China Hog Reduction?6:38 Heat Wave10:17 North Dakota Wheat Tour11:27 Ethanol Production
Story at-a-glance Used since 1406 CE in Chinese medicine, jiaogulan enhances stamina, lowers cholesterol, and supports metabolism, earning it the nickname “immortality herb” for its powerful benefits With an Oxygen Radical Absorbance Capacity (ORAC) value eight times higher than green tea, jiaogulan protects against cellular damage by neutralizing free radicals and reducing oxidative stress, which are key factors in aging and chronic disease Jiaogulan activates 5' adenosine monophosphate-activated protein kinase (AMPK), your body's energy switch, to enhance insulin sensitivity, block fat storage, and support cholesterol clearance — making it an effective ally in weight and blood sugar control This herb detoxifies the liver, improves circulation, and lowers inflammation through different flavor compounds, offering relief for conditions like fatty liver, high blood pressure, and chronic inflammation Studies show jiaogulan can shrink tumors, block cancer cell growth, and boost immunity — while sparing healthy tissue. Its natural compounds work across more than 30 cancer types, making it a promising adjunct therapy
Amid the wildfire around 15 miles outside of Area 51, the DoD is sweeping over where above-ground nuclear testing occurred. Some worry that the particulate from the fire may spread radioactive contamination into the air. It is being reported that current and former security detail at Groom Lake are suffering from unknown diseases and illnesses after being exposed to what is being called "An Invisible Enemy." There were also reports from whistleblowers that some scientists were exposed to radiation from so-called alien ship wreckage, resulting in many being taken off the base and sent home to their families. What is the government's response to these stories? Sadly, nothing. Listen tonight on Ground Zero with Clyde Lewis and UFO researcher, Joe Murgia, at 7 pm pacific time on groundzeroplus.com. Call in to the LIVE show at 503-225-0860. #groundzeroplus #ClydeLewis #Area51 #GroomLake #nucleartesting #radiation
Sitting down with Ash Pryor is like sitting down with burst of good energy. Brought the Peloton rowing instructor into the studio this week to talk about how she maintains a positive mindset, feels like her most strong and confident self, and the importance of staying true to your gut. She opens up about what it's like for her to teach and live as a bigger-bodied instructor, and what she hopes her presence teaches those that take her classes. IN THIS EPISODE(5:40) Ash talks about joining the rowing team at The Ohio State University(6:30) Emily and Ash define "NARP" (Non-Athletic Regular People)(8:28) What it is about rowing that brings Ash peace(11:00) What it was like for Ash to be one of three Black women on her collegiate team(14:30) How Ash navigated her mental health as a walk-on turned B1G champion(21:40) Ash shares the lessons she's learned about the importance of having grace with herself, and where she learned how to be compassionate with herself(25:55) Ash talks about her experience with Hashimoto's Disease and what her symptoms look like(31:20) Ash talks about the resiliency she's learned being an athlete(44:00) How Ash deals with negative feedback(55:00) What Ash learned running her first half-marathon earlier this year(55:22) How Ash shows up to give all she's got on the days when she's not feeling so shiny and bright.SOCIAL@ashpryor_thatsme@emilyabbate@hurdlepodcastOFFERSLMNT | Head to DrinkLMNT.com/Hurdle to get a free sample pack of their most popular flavors with your purchaseAG1 | Go drinkAG1.com/hurdle to get 5 free travel packs of NextGen AG1, a year's supply of AG D3/K2, and a welcome kit with your purchaseJOIN: The Daily Hurdle IG ChannelSIGN UP: Weekly Hurdle NewsletterASK ME A QUESTION: Email hello@hurdle.us to ask me a question!